131 related articles for article (PubMed ID: 24792401)
41. [Cost-benefit analysis of a population-based cervical cancer screening program designed for Cantabria].
Ramos-Barrón MÁ; Vázquez-Rodríguez JA; García-Garrido AB
Semergen; 2014 Sep; 40(6):296-304. PubMed ID: 24534799
[TBL] [Abstract][Full Text] [Related]
42. Outcomes from 8 years of cervical cancer screening at a rural screen-and-treat site in northern Tanzania.
Maillie L; Yussuph A; Chirangi B; Schroeder K
Int J Gynaecol Obstet; 2023 Feb; 160(2):604-611. PubMed ID: 36052864
[TBL] [Abstract][Full Text] [Related]
43. Awardee-specific economic costs of providing cancer screening and health promotional services to medically underserved women eligible in the National Breast and Cervical Cancer Early Detection Program.
Subramanian S; Ekwueme DU; Miller JW; Khushalani JS; Trogdon JG; Wong FL
Cancer Causes Control; 2019 Aug; 30(8):827-834. PubMed ID: 31111278
[TBL] [Abstract][Full Text] [Related]
44. Modeling cost-effectiveness of cervical cancer screening in Hungary.
Vokó Z; Nagyjánosi L; Margitai B; Kövi R; Tóth Z; László D; Kaló Z
Value Health; 2012 Jan; 15(1):39-45. PubMed ID: 22264970
[TBL] [Abstract][Full Text] [Related]
45. Cervical cancer screening in sub-Saharan Africa: a randomized trial of VIA versus cytology for triage of HPV-positive women.
Bigoni J; Gundar M; Tebeu PM; Bongoe A; Schäfer S; Fokom-Domgue J; Catarino R; Tincho EF; Bougel S; Vassilakos P; Petignat P
Int J Cancer; 2015 Jul; 137(1):127-34. PubMed ID: 25420434
[TBL] [Abstract][Full Text] [Related]
46. [Socioeconomic aspects of human immunodeficiency virus (HIV) infection in developing countries].
Gentilini M; Chieze F
Bull Acad Natl Med; 1990 Nov; 174(8):1209-19; discussion 1219-21. PubMed ID: 2094555
[TBL] [Abstract][Full Text] [Related]
47. Financial costs of pediatric cancer management in Africa: systematic review.
Mjumbe CK; Kulimba DM; Numbi OL; Nkumuyaya M; Balimo DM; Diyoka CK; Ilunga BK
Front Public Health; 2023; 11():1175560. PubMed ID: 37808990
[TBL] [Abstract][Full Text] [Related]
48. A Roadmap and Cost Implications of Establishing Comprehensive Cancer Care Using a Teleradiotherapy Network in a Group of Sub-Saharan African Countries With No Access to Radiation Therapy.
Datta NR; Heuser M; Bodis S
Int J Radiat Oncol Biol Phys; 2016 Aug; 95(5):1334-1343. PubMed ID: 27315665
[TBL] [Abstract][Full Text] [Related]
49. Cervix Cancer in Sub-Saharan Africa: An Assessment of Cervical Cancer Management.
Burt LM; McCormak M; Lecuru F; Kanyike DM; Bvochora-Nsingo M; Ndlovu N; Scott AA; Anorlu RI; Sharma V; Plante M; Nyongesa C; Tigeneh W; Fakie N; Suneja G; Gaffney DK
JCO Glob Oncol; 2021 Feb; 7():173-182. PubMed ID: 33529076
[TBL] [Abstract][Full Text] [Related]
50. Estimating the costs of HIV clinic integrated versus non-integrated treatment of pre-cancerous cervical lesions and costs of cervical cancer treatment in Kenya.
Vodicka EL; Chung MH; Zimmermann MR; Kosgei RJ; Lee F; Mugo NR; Okech TC; Sakr SR; Stergachis A; Garrison LP; Babigumira JB
PLoS One; 2019; 14(6):e0217331. PubMed ID: 31170193
[TBL] [Abstract][Full Text] [Related]
51. Cervical cancer prevention in Southern Africa: A review of national cervical cancer screening guidelines in the Southern African development community.
Adams RA; Botha MH
J Cancer Policy; 2024 Jun; 40():100477. PubMed ID: 38593950
[TBL] [Abstract][Full Text] [Related]
52. Experience of a 'Screen and treat' program for secondary prevention of cervical cancer in Uttar Pradesh, India.
Shikha S; Smita J; Nayanjeet C; Ruchi P; Parul S; Uma M; Shubhra T; Phillip G; Pritpal M
J Obstet Gynaecol Res; 2020 Feb; 46(2):320-327. PubMed ID: 31814247
[TBL] [Abstract][Full Text] [Related]
53. Trends in cervical cancer screening research in sub-Saharan Africa: A bibliometric analysis of publications from 2001 to 2020.
Khumalo PG; Carey M; Mackenzie L; Ampofo AG; Sanson-Fisher R
J Cancer Policy; 2022 Dec; 34():100356. PubMed ID: 35995396
[TBL] [Abstract][Full Text] [Related]
54. Estimating the costs of esophageal cancer screening, early diagnosis and treatment in three high risk areas in China.
Yang J; Wei WQ; Niu J; He YT; Liu ZC; Song GH; Zhao DL; Qiao YL; Yang CX
Asian Pac J Cancer Prev; 2011; 12(5):1245-50. PubMed ID: 21875275
[TBL] [Abstract][Full Text] [Related]
55. Brachytherapy infrastructure in sub-Saharan Africa and quest for cervical cancer elimination.
Tumba N; Theyra-Enias H
J Contemp Brachytherapy; 2022 Jun; 14(3):241-247. PubMed ID: 36199989
[TBL] [Abstract][Full Text] [Related]
56. Scaling-Up Cervical Cancer Screening and Treatment in Sub-Saharan Africa: Perspectives From Local Health Policymakers.
Sauvaget C; Selmouni F; Dangbemey DP; Kpebo DDO; Dieng NM; Nkele NN; Lucas E; Hounkpatin B; Chami Khazraji Y; Bennani M; Bekkali R; Basu P
JCO Glob Oncol; 2023 Jul; 9():e2300115. PubMed ID: 37441744
[No Abstract] [Full Text] [Related]
57. Program spending to increase adherence: South African cervical cancer screening.
Goldhaber-Fiebert JD; Denny LA; De Souza M; Kuhn L; Goldie SJ
PLoS One; 2009 May; 4(5):e5691. PubMed ID: 19492097
[TBL] [Abstract][Full Text] [Related]
58. [Estimating cost functions of cancer screening programs provided by municipalities].
Takemura S; Ohida T; Sone T; Ishii T; Fukuda T; Nakahara T; Kondo T
Nihon Koshu Eisei Zasshi; 2000 Dec; 47(12):1004-12. PubMed ID: 11201142
[TBL] [Abstract][Full Text] [Related]
59. Is India's public health care system prepared for cervical cancer screening?: Evaluating facility readiness from the fourth round of the District Level Household and Facility Survey (DLHS-4).
Dhillon PK; Hallowell BD; Agrawal S; Ghosh A; Yadav A; Van Dyne E; Senkomago V; Patel SA; Saraf D; Hariprasad R; Dumka N; Mehrotra R; Saraiya M
Prev Med; 2020 Sep; 138():106147. PubMed ID: 32473272
[TBL] [Abstract][Full Text] [Related]
60. What is the price of prevention? New evidence from a field experiment.
Okeke EN; Adepiti CA; Ajenifuja KO
J Health Econ; 2013 Jan; 32(1):207-18. PubMed ID: 23202265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
